$BBNX News
Last published 1w ago
- 1w agoBBNXBeta Bionics Announces Participation at Upcoming Investor ConferencesGlobeNewswireIRVINE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will participate at
- 2w agoBBNXBeta Bionics, Inc. Q3 2026 Earnings Conference Call & Webcast - BETA BIONICS INCEarnings Call TranscriptsGood afternoon, and welcome to the Beta Bionics 3rd Quarter 2026 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer ses
- 2w agoBBNXBeta Bionics, Inc. - PRESS RELEASEEarnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 2w agoBBNXBeta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 GuidanceGlobeNewswireIRVINE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the
- 2w agoBBNXGDDYHUBGPRCTImportant Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); Hub Group, Inc. (NASDAQ: HUBG); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX): Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ:BBNX). What is This Investigation
- 2w agoBBNXGDDYPRCTSMPLImportant Notice to Long-Term Shareholders of Beta Bionics, Inc. (NASDAQ: BBNX); GoDaddy Inc. (NYSE: GDDY); PROCEPT BioRobotics Corporation (NASDAQ: PRCT); and The Simply Good Foods Company (NASDAQ: SMPL): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX): Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ:BBNX). What is This Investigation
- 3w agoBBNXINVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Beta Bionics, Inc. to Contact Law FirmPR NewswireBeta Bionics, Inc. (NASDAQ:BBNX) shareholders should email fletcher@fmoorelaw.comNEW YORK, Oct. 19, 2026 /PRNewswire/ -- What is the Investigation
- 3w agoBBNXSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNXPR NewswireThe lawsuit contends Beta Bionics abandoned a built-in safety net for the iLet dosing algorithm and left more than 18,000 customer complaints uninvestigated, alleged operational failures that reached shareholders only
- 1mo agoBBNXKirby McInerney LLP Alerts Investors Who Acquired Beta Bionics, Inc. BBNX Securities Between July 30, 2025 and February 24, 2026 of Pending LawsuitBusiness WireKirby McInerney LLP reminds Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ:BBNX) investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a pending federal
- 1mo agoBBNXBeta Bionics Announces Closing of $172.5 Million Public Offering of Common StockGlobeNewswireIRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its common stock at a
- 1mo agoBBNXBBNX INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Beta Bionics, Inc. ShareholdersGlobeNewswireNEW YORK, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ:BBNX) securities to contact Lauren Molinaro
- 1mo agoAARDBBNXERASHUBGImportant Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Beta Bionics, Inc. (NASDAQ: BBNX); Erasca, Inc. (NASDAQ: ERAS); and Hub Group, Inc. (NASDAQ: HUBG): Grabar Law Office is Investigating Claims on Your BehalfGlobeNewswirePHILADELPHIA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (NASDAQ:AARD): Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ:AARD) shareholders who
- 1mo agoBBNXBeta Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded WarrantsGlobeNewswireIRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of
- 1mo agoBBNXBeta Bionics Announces Proposed Public Offering of $125.0 Million of Common StockGlobeNewswireIRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions,
- 1mo agoBBNXBeta Bionics Announces FDA Clearance of Mint™, the Company’s Transformative Patch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing AlgorithmGlobeNewswireMint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable Mint units during
- 1mo agoSENSBBNXSenseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic PancreasGlobeNewswirePairing year-long continuous glucose monitoring with automated insulin delivery to further simplify diabetes management for patients Brings Eversense 365 to the growing community of iLet Bionic Pancreas users Plan for
- 3mo agoBBNXBeta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 GuidanceGlobeNewswireIRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the
- 4mo agoBBNXBeta Bionics to Announce Second Quarter 2026 Financial Results on July 29, 2026GlobeNewswireIRVINE, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second
- 5mo agoBBNXRobbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for InformationGlobeNewswireSAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ:BBNX) to determine whether certain Beta Bionics officers and directors violated
- 5mo agoBBNXBeta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public WebsiteGlobeNewswireIRVINE, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that near real-time real-world data
- 5mo agoBBNXRobbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to ShareholdersBusiness WireShareholder Rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ:BBNX) to determine whether certain Beta Bionics officers and directors violated securities laws and breached fiduciary duties to
- 5mo agoBBNXBeta Bionics Updates Commercialization Timeline Expectations for Mint™, its Patch Pump in DevelopmentGlobeNewswireIRVINE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it expects to fully
- 6mo agoBBNX2026 GLOBAL HEALTHCARE CONFERENCE - BETA BIONICS INCEarnings Call TranscriptsYeah, thank you. So, Travis Steed here, the MedTech Analyst at Bank of America. Next up, we have Betabonics, Stephen Feeder. Stephen Feider. Feider, that's right. Okay. Chief Financial Officer. And we have Blake, Investo
- 6mo agoBBNXBeta Bionics to Present at the Bank of America Securities Health Care ConferenceGlobeNewswireIRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the
- 6mo agoBBNXBeta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceGlobeNewswireIRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the
- 7mo agoBBNXBeta Bionics Introduces Bionic Insights™ in Bionic Reports — Transforming How Clinicians Understand and Optimize Diabetes CareGlobeNewswireIRVINE, Calif., March 31, 2026 (GLOBE NEWSWIRE) -- Beta Bionics today announced the launch of Bionic Insights™, an innovative new feature within its Bionic Reports, designed to help healthcare providers (HCPs)
- 7mo agoBBNXBeta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026GlobeNewswireIRVINE, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first
- 7mo agoBBNXBBNX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the...
- 8mo agoBBNXINVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the...
- 8mo agoBBNXBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta BionicsBusiness WireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered
- 8mo agoBBNXBBNX SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered
- 8mo agoBBNXBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. ("Beta Bionics"...
- 8mo agoBBNXINVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered
- 8mo agoBBNXBeta Bionics to Present at the TD Cowen 46th Annual Health Care ConferenceGlobeNewswireIRVINE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at TD
- 8mo agoBBNXBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered
- 8mo agoBBNXBeta Bionics, Inc. Q4 and Full Year 2025 Earnings Conference Call & Webcast - BETA BIONICS INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Beta Bionics Inc. Q4 and full year 2025 earnings conference call and webcast. At this time, all participants are in a listen-only mode. Please be advised that today'
- 8mo agoBBNXBeta Bionics Announces Fourth Quarter and Full Year 2025 Financial Results and Introduces Annual Guidance for Full Year 2026GlobeNewswireIRVINE, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter
- 8mo agoBBNXBBNX SECURITIES ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Aquestive Therapeutics To Contact Him Directly To Discuss Their Options If you suffered
- 9mo agoBBNXINVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the...
- 9mo agoBBNXINVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Aquestive Therapeutics, Inc. ("Beta Bionics"...
- 9mo agoBBNXSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered
- 9mo agoBBNXSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsPR NewswireFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Beta Bionics, Inc. ("Beta Bionics" or the...
- 9mo agoBBNXBBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta BionicsGlobeNewswireFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Beta Bionics To Contact Him Directly To Discuss Their Options If you suffered
- 10mo agoBBNXBeta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026GlobeNewswireIRVINE, Calif., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth
- 10mo agoBBNXBeta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key MetricsGlobeNewswireIRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, unaudited topline
- 11mo agoBBNXBeta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026GlobeNewswireIRVINE, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX) (the "Company"), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to
- 1y agoBBNXBeta Bionics Announces Participation at Upcoming Investor ConferencesGlobeNewswireIRVINE, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at two
- 1y agoBBNXBeta Bionics, Inc. Q3 2025 Earnings Conference Call & Webcast - BETA BIONICS INCEarnings Call TranscriptsGood afternoon, and welcome to the Beta Bionics 3rd Quarter 2025 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question-and-answer ses
- 1y agoBBNXBeta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 GuidanceGlobeNewswireIRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter
- 1y agoBBNXBeta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025GlobeNewswireIRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third